ROS formed after cerebral ischemia can activate the polyol pathway enzyme aldose reductase (AR; also known as AKR1B1) by modifying its cysteine residues to sulfenic acids [9]. The gene discussed is AKR1B1; the disease is Cerebral ischemia.